Heidelberg Pharma AG

Share Issue/Capital Change • Aug 4, 2010

News Details

Ad-hoc | 4 August 2010 15:37

WILEX AG successfully completes rights issue

WILEX AG / Capital Increase

04.08.2010 15:37

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

• Not for distribution, publication or transmission
  in the USA, Canada, Japan and Australia -

WILEX AG successfully completes rights issue

Munich, Germany, 4 August 2010. The shareholders of WILEX AG (ISIN
DE0006614720 / WL6 / Frankfurt stock exchange) exercised their subscription
and oversubscription rights for all of the 2,455,070 new no-par value
bearer shares for EUR 4.10 per share by the end of the subscription period
on 3 August 2010. As a result, the Executive Management Board today
resolved with the approval of the Supervisory Board to set the total volume
of the rights issue at the maximum 2,455,070 new shares.

Shareholders exercised subscription rights for a total of 1,766,498 new
shares, which corresponds to a subscription ratio of approximately 72%. The
company's main shareholders - dievini Hopp BioTech holding GmbH & Co. KG,
Walldorf, Germany, and UCB Pharma S.A., Brussels, Belgium - exercised all
of their subscription rights.

A total of 688,572 shares were available under shareholders'
oversubscription rights. Since shareholders had placed oversubscription
rights for 3,275,479 shares, the rights issue was considerably
oversubscribed with the total demand amounting to 5,041,977 shares. Due to
this high level of oversubscription each oversubscription right placed will
result in an allocation ratio of approximately 21%.

WILEX AG plans to use the gross proceeds of approximately EUR 10 million
from the rights issue to finance its ongoing clinical studies and continued
growth as well as to enhance its equity position.

Following the entry of the capital increase in the Commercial Register -
which is scheduled for 5 August 2010 - the total number of WILEX shares
issued will increase to 18,413,035. The subscribed and allocated new WILEX
shares are expected to be delivered on 6 August 2010, after they have been
listed on the stock exchange. Trading of the new shares on the stock
exchange is also scheduled to commence on 6 August 2010. The sole lead
manager for the transaction was WestLB AG, Düsseldorf.

Important notes
This ad hoc release constitutes neither an offer to sell nor an invitation
to buy securities. In particular, this document constitutes neither an
offer to sell securities nor a solicitation of an offer to buy securities
in the United States of America. The shares of WILEX AG (the 'Shares') may
not be offered or sold in the United States of America or to or for the
account or benefit of 'U.S. persons' (as defined in Regulation S under the
U.S. Securities Act of 1933, as amended (the 'Securities Act')), unless
they have been registered or are exempt from registration under the
Securities Act. The Shares have not been and will not be registered under
the Securities Act. There will be no public offer of Shares in the United
States of America.

Contact
WILEX AG
Corporate Communications
Katja Arnold (CIRO)
Grillparzerstr. 10
81675 Munich, Germany
Tel.: +49 (0)89-41 31 38-126
Fax: +49 (0)89-41 31 38-99
E-mail: investors@wilex.com

This communication contains certain forward-looking statements relating to
the Company's business, which can be identified by the use of
forward-looking terminology such as 'estimates', 'believes', 'expects',
'may', 'will' 'should' 'future', 'potential' or similar expressions or by a
general discussion of the Company's strategy, plans or intentions. Such
forward-looking statements involve known and unknown risks, uncertainties
and other factors, which may cause our actual results of operations,
financial position, performance, or achievements, or industry results, to
be materially different from any future results, performance or
achievements expressed or implied by such forward-looking statements. Given
these uncertainties, prospective investors and partners are cautioned not
to place undue reliance on such forward-looking statements. We disclaim any
obligation to update any such forward-looking statements to reflect future
events or developments

04.08.2010 Ad hoc announcement, Financial News and Press Release distributed by DGAP.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language: English
Company: WILEX AG
Grillparzerstr. 10
81675 München
Deutschland
Phone: +49 (0)89 41 31 38 - 0
Fax: +49 (0)89 41 31 38 - 99
E-mail: info@wilex.com
Internet: www.wilex.com
ISIN: DE0006614720
WKN: 661472
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, München, Stuttgart

End of News DGAP News-Service

---